U.S. Markets closed

Zacks Market Edge Highlights: MJ, YOLO, THCX, TLRY and CRON

Zacks Equity Research

For Immediate Release

Chicago, IL – July 18, 2019 – Zacks Market Edge is a podcast hosted weekly by cks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:

Should You Buy a Cannabis ETF?

Welcome to Episode #186 of the Zacks Market Edge Podcast.

Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life.

This week she’s joined by Zacks Director of ETF Research, Neena Mishra, to talk about one of the hottest topics in ETFs: the cannabis ETFs.

For the past 2 years there has only been on player: the ETFMG Alternative Harvest ETF MJ. It used to be a Latin America real estate fund but in Dec 2017, it was changed to a cannabis fund.

Because it was the first one “in” it now has a market cap of over $1.1 billion.

The SEC was not amused by the sudden change in the fund’s purpose, however. Since its appearance, the SEC has put tough restrictions on companies who wanted to launch their own cannabis ETFs.

But finally, after months of vetting, some competitors have launched this year.

Two New Launches in 2019

1.       AdvisorShares Pure Cannabis ETF YOLO debuted in April 2019. This fund differs from MJ in that it is an actively managed fund and it is “pure” with companies that derive most of their revenue from cannabis. It’s largest holding is OrganiGram Holdings versus MJ’s largest holding of GW Pharmaceuticals.

2.       The Cannabis ETF THCX is just days old. This passively managed fund has 35 holdings. It has the cheapest expense ratio at 0.7%. It’s largest holding differs from the other two funds as it is Tilray TLRY, followed by Cronos Group CRON.

Amplify is set to launch its own actively managed cannabis ETF shortly and a fifth fund is also expected under the ticker, TOKE, in the coming weeks.

Should investors be diving into the pot stocks through these ETFs?

Learn what the differences are between them, and the pros and cons of ETF investing, on this week’s podcast.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339



Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.